VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
7 hedge funds and large institutions have $462K invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2013 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Hudson Bay Capital Management
Stamford,
Connecticut
|
$47K |
| 2 |
SSG
2
Summit Securities Group
New York
|
$6K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$1K |
Top Sellers
| 1 |
U
1
UBS
Zurich,
Switzerland
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SIM
1
Sigma Investment Management
Portland,
Oregon
| $176K | 120,000 | – | – |
|
|
WS
2
Wedbush Securities
Los Angeles,
California
| $104K | 70,891 | – | – |
|
3
California Public Employees Retirement System
Sacramento,
California
| $101K | 91,065 | – | – |
|
|
4
Hudson Bay Capital Management
Stamford,
Connecticut
| $47K | 143,886 | +143,886 | New |
|
5
LSV Asset Management
Chicago,
Illinois
| $27K | 24,731 | – | – |
|
|
SSG
6
Summit Securities Group
New York
| $6K | 5,687 | +5,687 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $1K | 800 | +396 | +98% |
|
|
U
8
UBS
Zurich,
Switzerland
| – | – | -5,448 | Closed |
|